Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-critical care
•
Child Neurology
•
Hospital Medicine
How do you use amantadine and assess its efficacy for comatose pediatric patients?
Related Questions
How do you approach treatment of vasospasm after AVM rupture?
How frequently, and in which situations do you use quantitative EEG for the detection and/or monitoring of delayed cerebral ischemia after aneurysmal SAH?
When do you usually introduce conversations regarding tracheostomy placement in patients with refractory status epilepticus, or other conditions where one may anticipate delayed awakening?
Do you use dual anti-platelet therapy inpatients with low NIHSS who have had bilateral brainstem strokes?
When would you consider lacosamide for treatment of status epilepticus in patients with prolonged PR interval or first degree AV block?
When do you consider testing with stroke gene panels in young stroke patients?
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
When do you consider surgery for patients with Sturge Weber?
When do you consider cannabidiol for treatment of epilepsy?
What is your approach to a pediatric patient presenting with a new daily persistent headache?
